Evidence map›Paper›PMID 38001256›Full record

ArticleCell death and differentiation2024

Non-canonical BIM-regulated energy metabolism determines drug-induced liver necrosis.

Rebekka Lambrecht, Franziska Rudolf, Anna-Katharina Ückert, Valentina C Sladky, Truong San Phan, Jasmin Jansen, Samara Naim, Thomas Kaufmann, Adrian Keogh, Susanne Kirschnek and 5 more

Open access · hybridAbstract read
In one paragraph

Article in Cell death and differentiation, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
3.0field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 14 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 7 institutions in 3 countries.

Rebekka LambrechtBiochemical Pharmacology, Department of Biology, University of Konstanz, Universitätsstrasse 10, 78464, Konstanz, Germany.ORCID 0000-0002-7717-1778
Franziska RudolfBiochemical Pharmacology, Department of Biology, University of Konstanz, Universitätsstrasse 10, 78464, Konstanz, Germany.
Anna-Katharina ÜckertIn vitro Toxicology and Biomedicine, Department of Biology, University of Konstanz, Universitätsstrasse 10, 78464, Konstanz, Germany.
Valentina C SladkyInstitute for Developmental Immunology, Biocenter, Medical University of Innsbruck, Innrain 80, 6020, Innsbruck, Austria.
Truong San PhanBiochemical Pharmacology, Department of Biology, University of Konstanz, Universitätsstrasse 10, 78464, Konstanz, Germany.ORCID 0000-0002-8837-5119
Jasmin JansenBiochemistry and Mass Spectrometry, Department of Biology, University of Konstanz, Universitätsstrasse 10, 78464, Konstanz, Germany.
Samara NaimInstitute of Pharmacology, University of Bern, Inselspital, Bern University Hospital, INO-F, Freiburgstrasse 16C, 3010, Bern, Switzerland.
Thomas KaufmannInstitute of Pharmacology, University of Bern, Inselspital, Bern University Hospital, INO-F, Freiburgstrasse 16C, 3010, Bern, Switzerland.ORCID 0000-0001-9906-874X
Adrian KeoghVisceral and Transplantation Surgery, Department of Clinical Research, Inselspital, Bern University Hospital, 3008, Bern, Switzerland.
Susanne KirschnekFaculty of Medicine, Institute of Medical Microbiology and Hygiene, Medical Center, University of Freiburg, 79104, Freiburg, Germany.ORCID 0000-0001-7771-7817
Aswin MangerichNutritional Toxicology, Institute of Nutritional Science, University of Potsdam, Arthur-Scheunert-Allee 114-116, 14558, Nuthetal, Germany.ORCID 0000-0001-9742-2338
Florian StengelBiochemistry and Mass Spectrometry, Department of Biology, University of Konstanz, Universitätsstrasse 10, 78464, Konstanz, Germany.
Marcel LeistIn vitro Toxicology and Biomedicine, Department of Biology, University of Konstanz, Universitätsstrasse 10, 78464, Konstanz, Germany.ORCID 0000-0002-3778-8693
Andreas VillungerInstitute for Developmental Immunology, Biocenter, Medical University of Innsbruck, Innrain 80, 6020, Innsbruck, Austria.ORCID 0000-0001-8259-4153
Thomas BrunnerBiochemical Pharmacology, Department of Biology, University of Konstanz, Universitätsstrasse 10, 78464, Konstanz, Germany. thomas.brunner@uni-konstanz.de.ORCID 0000-0002-1594-4712
University of Konstanz · DEUniversity of Bern · CHAustrian Academy of Sciences · ATInnsbruck Medical University · ATUniversity Hospital of Bern · CHUniversity of Freiburg · DEUniversity of Potsdam · DE

Funding

Deutsche Forschungsgemeinschaft (German Research Foundation) BR 3369/5-2Deutsche Forschungsgemeinschaft (German Research Foundation) INST 38/646-1Deutsche Forschungsgemeinschaft (German Research Foundation) INST 38/657-1
6 · The paper itself

Abstract

Paracetamol (acetaminophen, APAP) overdose severely damages mitochondria and triggers several apoptotic processes in hepatocytes, but the final outcome is fulminant necrotic cell death, resulting in acute liver failure and mortality. Here, we studied this switch of cell death modes and demonstrate a non-canonical role of the apoptosis-regulating BCL-2 homolog BIM/Bcl2l11 in promoting necrosis by regulating cellular bioenergetics. BIM deficiency enhanced total ATP production and shifted the bioenergetic profile towards glycolysis, resulting in persistent protection from APAP-induced liver injury. Modulation of glucose levels and deletion of Mitofusins confirmed that severe APAP toxicity occurs only in cells dependent on oxidative phosphorylation. Glycolytic hepatocytes maintained elevated ATP levels and reduced ROS, which enabled lysosomal recycling of damaged mitochondria by mitophagy. The present study highlights how metabolism and bioenergetics affect drug-induced liver toxicity, and identifies BIM as important regulator of glycolysis, mitochondrial respiration, and oxidative stress signaling.

Indexed as

AcetaminophenChemical and Drug Induced Liver InjuryAdenosine TriphosphateBcl-2-Like Protein 11Energy MetabolismHepatocytesHumansLiverMitochondria, LiverNecrosisOxidative StressAcetaminophenAdenosine TriphosphateBcl-2-Like Protein 11

Identifiers

PMID38001256
PMCPMC10781779
OpenAlexW4388971637

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.